379 related articles for article (PubMed ID: 34127537)
1.
Dotz V; Visconti A; Lomax-Browne HJ; Clerc F; Hipgrave Ederveen AL; Medjeral-Thomas NR; Cook HT; Pickering MC; Wuhrer M; Falchi M
J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
[TBL] [Abstract][Full Text] [Related]
3. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M
J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555
[TBL] [Abstract][Full Text] [Related]
4. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
Leung JC; Poon PY; Lai KN
J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
[TBL] [Abstract][Full Text] [Related]
5. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
Odani H; Hiki Y; Takahashi M; Nishimoto A; Yasuda Y; Iwase H; Shinzato T; Maeda K
Biochem Biophys Res Commun; 2000 Apr; 271(1):268-74. PubMed ID: 10777713
[TBL] [Abstract][Full Text] [Related]
6. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
7. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
Stuchlova Horynova M; Vrablikova A; Stewart TJ; Takahashi K; Czernekova L; Yamada K; Suzuki H; Julian BA; Renfrow MB; Novak J; Raska M
Nephrol Dial Transplant; 2015 Feb; 30(2):234-8. PubMed ID: 25281698
[TBL] [Abstract][Full Text] [Related]
8. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
Nakazawa S; Imamura R; Kawamura M; Kato T; Abe T; Namba T; Iwatani H; Yamanaka K; Uemura M; Kishikawa H; Nishimura K; Oka K; Tajiri M; Wada Y; Nonomura N
Biochem Biophys Res Commun; 2019 Jan; 508(4):1106-1112. PubMed ID: 30553446
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
[TBL] [Abstract][Full Text] [Related]
10. Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation.
Ohyama Y; Yamaguchi H; Nakajima K; Mizuno T; Fukamachi Y; Yokoi Y; Tsuboi N; Inaguma D; Hasegawa M; Renfrow MB; Novak J; Yuzawa Y; Takahashi K
Sci Rep; 2020 Jan; 10(1):671. PubMed ID: 31959827
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J
PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438
[TBL] [Abstract][Full Text] [Related]
12. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
Suzuki H; Raska M; Yamada K; Moldoveanu Z; Julian BA; Wyatt RJ; Tomino Y; Gharavi AG; Novak J
J Biol Chem; 2014 Feb; 289(8):5330-9. PubMed ID: 24398680
[TBL] [Abstract][Full Text] [Related]
13. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
14. Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.
Takahashi K; Wall SB; Suzuki H; Smith AD; Hall S; Poulsen K; Kilian M; Mobley JA; Julian BA; Mestecky J; Novak J; Renfrow MB
Mol Cell Proteomics; 2010 Nov; 9(11):2545-57. PubMed ID: 20823119
[TBL] [Abstract][Full Text] [Related]
15. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
Linossier MT; Palle S; Berthoux F
Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
[TBL] [Abstract][Full Text] [Related]
16. Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals.
Lehoux S; Mi R; Aryal RP; Wang Y; Schjoldager KT; Clausen H; van Die I; Han Y; Chapman AB; Cummings RD; Ju T
Mol Cell Proteomics; 2014 Nov; 13(11):3097-113. PubMed ID: 25071157
[TBL] [Abstract][Full Text] [Related]
17. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
18. Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice.
Nishie T; Miyaishi O; Azuma H; Kameyama A; Naruse C; Hashimoto N; Yokoyama H; Narimatsu H; Wada T; Asano M
Am J Pathol; 2007 Feb; 170(2):447-56. PubMed ID: 17255313
[TBL] [Abstract][Full Text] [Related]
19. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Tomana M; Novak J; Julian BA; Matousovic K; Konecny K; Mestecky J
J Clin Invest; 1999 Jul; 104(1):73-81. PubMed ID: 10393701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]